tiprankstipranks
Trending News
More News >
BrightSpring Health Services, Inc. (BTSG)
NASDAQ:BTSG
US Market
Advertisement

BrightSpring Health Services, Inc. (BTSG) AI Stock Analysis

Compare
272 Followers

Top Page

BTSG

BrightSpring Health Services, Inc.

(NASDAQ:BTSG)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 4o)
Rating:67Neutral
Price Target:
$37.00
▲(8.66% Upside)
BrightSpring Health Services has a moderate overall stock score of 67. The most significant factors include strong earnings call performance with increased guidance and robust revenue growth. However, financial performance is constrained by high leverage and low profitability margins. Technical analysis shows bullish momentum, but overbought conditions could lead to a pullback. The valuation is a concern due to a high P/E ratio and lack of dividend yield.
Positive Factors
Revenue Growth
The significant revenue growth reflects strong market demand and effective business strategies, positioning the company for sustained expansion.
Operational Efficiency
Improved operational efficiency and cash flow generation enhance financial stability and provide resources for future investments.
Quality and Patient Satisfaction
High quality and patient satisfaction scores strengthen the company's reputation and competitive position, supporting long-term client retention.
Negative Factors
High Leverage
High leverage can limit financial flexibility and increase risk, potentially impacting the company's ability to invest in growth opportunities.
Profitability Margins
Low profitability margins indicate challenges in cost management and pricing power, which could hinder long-term financial performance.
Community Living Divestiture Delay
Delays in strategic divestitures can impact financial restructuring plans and delay potential improvements in operational focus and efficiency.

BrightSpring Health Services, Inc. (BTSG) vs. SPDR S&P 500 ETF (SPY)

BrightSpring Health Services, Inc. Business Overview & Revenue Model

Company DescriptionBrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
How the Company Makes MoneyBrightSpring Health Services generates revenue through multiple channels, primarily by providing direct care services to individuals through government contracts, private insurance reimbursements, and out-of-pocket payments from clients. Key revenue streams include Medicaid-funded services, which make up a significant portion of their income, as well as partnerships with healthcare providers and community organizations that enhance service delivery. Additionally, the company invests in technology solutions that improve operational efficiency and care outcomes, contributing to cost savings and revenue growth. Strategic alliances with healthcare systems and participation in value-based care models further bolster its financial performance.

BrightSpring Health Services, Inc. Earnings Call Summary

Earnings Call Date:Oct 28, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Feb 26, 2026
Earnings Call Sentiment Positive
The earnings call reflected strong financial performance, with significant revenue and EBITDA growth across segments, especially in Pharmacy Solutions and Provider Services. The company successfully launched new therapies in Specialty Pharmacy and reported high patient satisfaction. However, challenges such as flat EBITDA margins, home health rate concerns, and a customer bankruptcy were noted. Overall, the positive aspects outweighed the negative, indicating a strong outlook.
Q2-2025 Updates
Positive Updates
Strong Revenue and EBITDA Growth
BrightSpring reported a 29% year-over-year increase in total company revenue, reaching $3.1 billion. Adjusted EBITDA also grew by 29% to $143 million in the second quarter of 2025.
Pharmacy Solutions Segment Success
Pharmacy Solutions revenue grew 32% year-over-year to $2.8 billion, driven by a 39% increase in Infusion and Specialty revenue and an 11% increase in Home & Community Pharmacy revenue.
Provider Services Expansion
Provider Services revenue grew 11% year-over-year to $358 million, with home healthcare revenue up 17%, rehab revenue up 9%, and personal care revenue up 4%.
Market Leadership in Specialty Pharmacy
Specialty scripts grew 38% in the second quarter, with 5 LDD launches. The LDD portfolio expanded to 133 therapies, with plans for 16 to 18 additional launches over the next 12 to 18 months.
High Patient Satisfaction and Performance Metrics
BrightSpring reported high patient satisfaction scores across various segments, including a 99% satisfaction score in rehab and a 98% timely initiation of care in home health.
Updated 2025 Guidance
The company increased its total revenue guidance to $12.2 billion to $12.6 billion and adjusted EBITDA guidance to $590 million to $605 million for the full year 2025.
Negative Updates
Flat EBITDA Margin
Despite revenue growth, the EBITDA margin remained flat at 4.5% compared to the second quarter of last year.
Home Health Rate Concerns
The preliminary home health rate was not adequate to cover annual expense increases and operational needs, posing potential future challenges.
Bankruptcy Impact on Home & Community Pharmacy
A Home & Community Pharmacy customer filed for bankruptcy, although BrightSpring plans to continue service and has accounted for the impact in Q2 results.
Company Guidance
During the second quarter of 2025, BrightSpring Health Services reported impressive financial results, with revenue and adjusted EBITDA both growing approximately 30% compared to the same period last year. The company's total revenue reached $3.1 billion, marking a 29% increase year-over-year. Pharmacy Solutions revenue was particularly strong at $2.8 billion, up 32%, while Provider Services revenue increased by 11% to $358 million. BrightSpring's adjusted EBITDA for the quarter was $143 million, maintaining an EBITDA margin of 4.5%. Given the robust performance, the company raised its 2025 guidance, projecting adjusted EBITDA to be between $590 million and $605 million, reflecting a growth rate of 31.5% compared to 2024. The company also highlighted significant operational achievements, including 38% growth in specialty scripts and strong performance across all service lines, contributing to its optimistic outlook for the remainder of the year and into 2026.

BrightSpring Health Services, Inc. Financial Statement Overview

Summary
BrightSpring Health Services shows strong revenue and cash flow improvements, but faces challenges with profitability and leverage. Continued focus on enhancing net margins and reducing debt is crucial for long-term financial health.
Income Statement
65
Positive
BrightSpring Health Services has shown a positive revenue growth trajectory, with revenue increasing significantly over recent years. The TTM revenue grew by 6.4% from the previous annual figure. Gross profit and EBIT margins are stable, though net profit margin is low due to relatively small net income. Despite profitability challenges, the company demonstrates strong revenue expansion.
Balance Sheet
58
Neutral
The company's debt-to-equity ratio has improved, reflecting reduced leverage, though it remains a concern with high total liabilities. Stockholders' equity has strengthened, supporting a better equity ratio. Return on equity shows improvement but remains modest, highlighting the need for better profitability to enhance shareholder value.
Cash Flow
72
Positive
Operating cash flow has improved significantly, and free cash flow has turned positive, indicating better cash management. The free cash flow to net income ratio is favorable, suggesting efficient cash conversion. However, fluctuations in cash flow in previous years suggest potential volatility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue12.41B11.27B8.83B7.72B6.70B5.58B
Gross Profit1.53B1.59B1.43B1.35B1.25B1.05B
EBITDA445.83M398.13M349.52M391.80M433.34M346.69M
Net Income129.59M-18.06M-154.60M-53.91M49.80M20.81M
Balance Sheet
Total Assets6.05B5.93B5.53B5.64B5.51B4.73B
Cash, Cash Equivalents and Short-Term Investments140.34M61.25M13.07M13.63M46.73M262.00M
Total Debt233.99M2.90B3.67B3.68B3.77B2.97B
Total Liabilities4.23B4.27B4.92B4.85B4.71B4.00B
Stockholders Equity1.82B1.65B584.74M754.78M774.82M704.98M
Cash Flow
Free Cash Flow276.09M-57.14M137.26M-74.77M210.90M170.73M
Operating Cash Flow349.22M23.77M210.78M-4.65M270.17M222.64M
Investing Cash Flow-86.97M-140.24M-134.43M45.36M-1.19B-451.85M
Financing Cash Flow-156.92M164.65M-76.91M-73.81M705.22M472.92M

BrightSpring Health Services, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price34.05
Price Trends
50DMA
27.95
Positive
100DMA
24.68
Positive
200DMA
22.41
Positive
Market Momentum
MACD
1.79
Negative
RSI
76.01
Negative
STOCH
92.31
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BTSG, the sentiment is Positive. The current price of 34.05 is above the 20-day moving average (MA) of 30.71, above the 50-day MA of 27.95, and above the 200-day MA of 22.41, indicating a bullish trend. The MACD of 1.79 indicates Negative momentum. The RSI at 76.01 is Negative, neither overbought nor oversold. The STOCH value of 92.31 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BTSG.

BrightSpring Health Services, Inc. Risk Analysis

BrightSpring Health Services, Inc. disclosed 57 risk factors in its most recent earnings report. BrightSpring Health Services, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

BrightSpring Health Services, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$3.13B218.392.32%12.05%-2.46%
$1.64B32.4110.94%9.62%-6.61%
$2.33B127.483.56%2.99%-24.79%-78.38%
$6.14B56.844.25%17.23%
$3.89B43.35%-430.79%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
$775.56M-4.11-13.38%-6.71%-71.40%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BTSG
BrightSpring Health Services, Inc.
34.05
19.08
127.45%
PINC
Premier
28.11
8.71
44.90%
EVH
Evolent Health
6.60
-16.75
-71.73%
PGNY
Progyny
18.65
3.60
23.92%
PRVA
Privia Health Group
25.60
7.24
39.43%
HNGE
Hinge Health, Inc. Class A
48.66
8.50
21.17%

BrightSpring Health Services, Inc. Corporate Events

BrightSpring Health Services Reports Strong Q3 2025 Results
Oct 29, 2025

BrightSpring Health Services, Inc. is a prominent provider of home and community-based health services, focusing on complex populations with specialized and chronic care needs across the United States. The company operates in the healthcare sector, delivering integrated care solutions through various service lines, including pharmacy, home health care, and rehabilitation.

Stock BuybackPrivate Placements and FinancingRegulatory Filings and Compliance
BrightSpring Completes Stock Offering with KKR and BofA
Neutral
Oct 22, 2025

On October 20, 2025, BrightSpring Health Services, Inc. entered into an underwriting agreement with KKR Phoenix Aggregator L.P., Management Selling Stockholders, and BofA Securities, Inc. for an underwritten offering of 15,000,000 shares of its common stock. The offering, which closed on October 22, 2025, involved the sale of shares by the Selling Stockholders, with the company not receiving any proceeds except from the exercise of stock options by management. BrightSpring also repurchased 1,500,000 shares from the underwriter without incurring underwriting fees. This transaction was conducted under an automatic shelf registration statement filed with the SEC, and included customary conditions and indemnification obligations.

The most recent analyst rating on (BTSG) stock is a Buy with a $32.00 price target. To see the full list of analyst forecasts on BrightSpring Health Services, Inc. stock, see the BTSG Stock Forecast page.

BrightSpring Health Services Reports Strong Q2 2025 Results
Aug 2, 2025

BrightSpring Health Services, Inc., a prominent provider of home and community-based health services for complex populations, operates in the healthcare sector, offering integrated care solutions across all 50 states.

BrightSpring Health Services Reports Strong Earnings Growth
Aug 2, 2025

BrightSpring Health Services, Inc. recently held its earnings call, revealing a generally positive sentiment with strong revenue and EBITDA growth. The company reported significant achievements, particularly in its Pharmacy Solutions and Provider Services segments. Despite some challenges such as a flat EBITDA margin and modest impacts from home health rate inadequacies, the overall highlights of the call significantly outweighed the lowlights, painting a promising picture for the company’s future.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025